Insufficient scRNA-seq data for expression of HYPK at single-cell level.
Insufficient scRNA-seq data for expression of HYPK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 256.88 | 89 / 89 | 2% | 0.03 | 17 / 901 |
| ovary | 100% | 302.04 | 180 / 180 | 2% | 0.03 | 8 / 430 |
| lung | 100% | 558.09 | 578 / 578 | 2% | 0.03 | 20 / 1155 |
| bladder | 100% | 240.05 | 21 / 21 | 2% | 0.03 | 8 / 504 |
| prostate | 100% | 421.08 | 245 / 245 | 1% | 0.02 | 4 / 502 |
| stomach | 100% | 310.31 | 358 / 359 | 1% | 0.01 | 3 / 286 |
| intestine | 100% | 319.44 | 964 / 966 | 1% | 0.01 | 5 / 527 |
| breast | 100% | 273.20 | 458 / 459 | 1% | 0.02 | 10 / 1118 |
| uterus | 100% | 286.03 | 170 / 170 | 1% | 0.01 | 3 / 459 |
| thymus | 100% | 413.84 | 653 / 653 | 0% | 0.00 | 2 / 605 |
| adipose | 100% | 282.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 100% | 330.55 | 258 / 258 | 0% | 0 | 0 / 230 |
| spleen | 100% | 386.50 | 241 / 241 | 0% | 0 | 0 / 0 |
| esophagus | 99% | 246.16 | 1436 / 1445 | 1% | 0.01 | 1 / 183 |
| pancreas | 99% | 174.03 | 325 / 328 | 1% | 0.01 | 1 / 178 |
| skin | 100% | 261.85 | 1800 / 1809 | 0% | 0 | 0 / 472 |
| liver | 99% | 181.81 | 224 / 226 | 0% | 0 | 0 / 406 |
| muscle | 99% | 181.84 | 791 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 208.34 | 845 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 96% | 205.94 | 1281 / 1335 | 0% | 0 | 0 / 0 |
| brain | 92% | 261.98 | 2437 / 2642 | 2% | 0.03 | 15 / 705 |
| peripheral blood | 88% | 161.01 | 821 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.05 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006457 | Biological process | protein folding |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0050821 | Biological process | protein stabilization |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0015630 | Cellular component | microtubule cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0044183 | Molecular function | protein folding chaperone |
| GO_0005515 | Molecular function | protein binding |
| Gene name | HYPK |
| Protein name | Huntingtin interacting protein K Huntingtin-interacting protein K (Huntingtin yeast partner K) |
| Synonyms | HSPC136 C15orf63 |
| Description | FUNCTION: Component of several N-terminal acetyltransferase complexes . Inhibits the N-terminal acetylation activity of the N-terminal acetyltransferase NAA10-NAA15 complex (also called the NatA complex) . Has chaperone-like activity preventing polyglutamine (polyQ) aggregation of HTT in neuronal cells probably while associated with the NatA complex . May play a role in the NatA complex-mediated N-terminal acetylation of PCNP . . |
| Accessions | J3QT56 ENST00000406925.6 [Q9NX55-2] ENST00000458412.2 ENST00000442995.4 [Q9NX55-2] Q9NX55 |